The Future of Analytical and Interpretative Toxicology: Where are We Going and How Do We Get There?

被引:6
作者
Wille, Sarah M. R. [1 ]
Elliott, Simon [2 ,3 ]
机构
[1] Natl Inst Criminalist & Criminol, Dept Toxicol, Brussels, Belgium
[2] Elliott Forens Consulting Ltd, Birmingham, W Midlands, England
[3] Kings Coll London, Dept Analyt Environm & Forens Sci, London, England
关键词
DEPENDENT POSTMORTEM REDISTRIBUTION; ALTERNATIVE MATRICES; DRUG-INTERACTIONS; PSYCHOACTIVE SUBSTANCES; ACUTE INTOXICATION; POTENTIAL MARKERS; OPIOID WITHDRAWAL; BAYESIAN NETWORK; BLOOD-SAMPLES; PHARMACOGENETICS;
D O I
10.1093/jat/bkaa133
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
(Forensic) toxicology has faced many challenges, both analytically and interpretatively, especially in relation to an increase in potential drugs of interest. Analytical toxicology and its application to medicine and forensic science have progressed rapidly within the past centuries. Technological innovations have enabled detection of more substances with increasing sensitivity in a variety of matrices. Our understanding of the effects (both intended and unintended) have also increased along with determination and degree of toxicity. However, it is clear there is even more to understand and consider. The analytical focus has been on typical matrices such as blood and urine but other matrices could further increase our understanding, especially in postmortem (PM) situations. Within this context, the role of PM changes and potential redistribution of drugs requires further research and identification of markers of its occurrence and extent. Whilst instrumentation has improved, in the future, nanotechnology may play a role in selective and sensitive analysis as well as bioassays. Toxicologists often only have an advisory impact on pre-analytical and pre-interpretative considerations. The collection of appropriate samples at the right time in an appropriate way as well as obtaining sufficient circumstance background is paramount in ensuring an effective analytical strategy to provide useful results that can be interpreted within context. Nevertheless, key interpretative considerations such as pharmacogenomics and drug-drug interactions as well as determination of tolerance remain and in the future, analytical confirmation of an individual's metabolic profile may support a personalized medicine and judicial approach. This should be supported by the compilation and appropriate application of drug data pursuant to the situation. Specifically, in PM circumstances, data pertaining to where a drug was not/may have been/was contributory will be beneficial with associated pathological considerations. This article describes the challenges faced within toxicology and discusses progress to a future where they are being addressed.
引用
收藏
页码:619 / 632
页数:14
相关论文
共 124 条
[81]   ABCB1 gene polymorphisms are associated with suicide in forensic autopsies [J].
Moreno, Samuel Boiso ;
Zackrisson, Anna-Lena ;
Falk, Ingrid Jakobsen ;
Karlsson, Louise ;
Carlsson, Bjorn ;
Tillmar, Andreas ;
Kugelberg, Fredrik C. ;
Ahlner, Johan ;
Hagg, Staffan ;
Green, Henrik .
PHARMACOGENETICS AND GENOMICS, 2013, 23 (09) :463-469
[82]   Pharmacogenetics and forensic toxicology [J].
Musshoff, Frank ;
Stamer, Ulrike M. ;
Madea, Burkhard .
FORENSIC SCIENCE INTERNATIONAL, 2010, 203 (1-3) :53-62
[83]   A Metabolomics Study of Retrospective Forensic Data from Whole Blood Samples of Humans Exposed to 3,4-Methylenedioxymethamphetamine: A New Approach for Identifying Drug Metabolites and Changes in Metabolism Related to Drug Consumption [J].
Nielsen, Kirstine L. ;
Telving, Rasmus ;
Andreasen, Mette F. ;
Hasselstrom, Jorgen B. ;
Johannsen, Mogens .
JOURNAL OF PROTEOME RESEARCH, 2016, 15 (02) :619-627
[84]   Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors [J].
Noble, Carolina ;
Cannaert, Annelies ;
Linnet, Kristian ;
Stove, Christophe P. .
DRUG TESTING AND ANALYSIS, 2019, 11 (03) :501-511
[85]  
Ozarda Y, 2016, BIOCHEM MEDICA, V26, P5, DOI 10.11613/BM.2016.001
[86]   Fatal intravenous injection of potassium: Is postmortem biochemistry useful for the diagnosis? [J].
Palmiere, Cristian ;
Scarpelli, Maria Pia ;
Varlet, Vincent ;
Baumann, Pia ;
Michaud, Katarzyna ;
Augsburger, Marc .
FORENSIC SCIENCE INTERNATIONAL, 2017, 274 :27-32
[87]   Postmortem biochemistry in suspected starvation-induced ketoacidosis [J].
Palmiere, Cristian ;
Tettamanti, Camilla ;
Augsburger, Marc ;
Burkhardt, Sandra ;
Sabatasso, Sara ;
Lardi, Christelle ;
Werner, Dominique .
JOURNAL OF FORENSIC AND LEGAL MEDICINE, 2016, 42 :51-55
[88]   Method Development in Forensic Toxicology [J].
Peters, Frank T. ;
Wissenbach, Dirk K. ;
Busardo, Francesco Paolo ;
Marchei, Emilia ;
Pichini, Simona .
CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (36) :5455-5467
[89]   Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances [J].
Pottie, Eline ;
Cannaert, Annelies ;
Van Uytfanghe, Katleen ;
Stove, Christophe P. .
ANALYTICAL CHEMISTRY, 2019, 91 (24) :15444-15452
[90]   DNA quality and quantity from up to 16 years old post-mortem blood stored on FTA cards [J].
Rahikainen, Anna-Liina ;
Palo, Jukka U. ;
de Leeuw, Wiljo ;
Budowle, Bruce ;
Sajantila, Antti .
FORENSIC SCIENCE INTERNATIONAL, 2016, 261 :148-153